Non-Interventional Study On The Treatment With Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia Or Mixed Dyslipidemia
Latest Information Update: 19 Feb 2024
At a glance
- Drugs Bempedoic acid (Primary) ; Bempedoic acid/ezetimibe (Primary)
- Indications Dyslipidaemias; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms MILOS-Spain
- Sponsors Daiichi Sankyo Europe
Most Recent Events
- 29 Nov 2023 Status changed from not yet recruiting to withdrawn prior to enrolment due to non-availability of patients.
- 26 Apr 2023 Planned initiation date changed from 1 Apr 2023 to 1 Sep 2023.
- 06 Apr 2023 New trial record